Neuronetics (STIM) Other financing activities (2017 - 2025)

Neuronetics (STIM) posted quarterly Other financing activities of $4000.0 for Q3 2025, up 300.0% quarter-over-quarter from $1000.0 in Q2 2025.

Neuronetics (STIM) Other financing activities (2017 - 2025) Analysis & Trends

Neuronetics (STIM) has reported Other financing activities for 8 consecutive years, with $4000.0 the latest figure, recorded in Q3 2025.

In Q3 2025, Other financing activities changed N/A year-over-year to $4000.0; the TTM figure through Dec 2025 stood at $13000.0 (down 99.54% YoY), while the FY2025 annual figure was $13000.0, down 99.48% from the prior year.
Other financing activities climbed to $4000.0 in Q3 2025 per STIM's latest filing, from $1000.0 in the prior quarter.
Across five years, Other financing activities topped out at $2.5 million in Q4 2024 and bottomed at $1000.0 in Q2 2025.
Historically, Other financing activities has averaged $478727.3 across 4 years, with a median of $43000.0 in 2022.
Annual changes were most pronounced in 2021 — Other financing activities jumped 1994.74% — and 2022, when it plunged 99.43%.
Neuronetics' Other financing activities stood at $32000.0 in 2021, then soared by 668.75% to $246000.0 in 2022, then surged by 924.39% to $2.5 million in 2024, then tumbled by 99.84% to $4000.0 in 2025.
Business Quant data shows STIM's Other financing activities at $4000.0 in Q3 2025, $1000.0 in Q2 2025, and $8000.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Neuronetics	225.97 Mn	206.54 Mn	21.22 Mn

Download Data